New technique can track drug and gene delivery to cells

May 22, 2018 by Liz Ahlberg Touchstone, University of Illinois at Urbana-Champaign
The technique allows them to count, map and track delivery agents, shown in red, as they enter and move through a cell. Credit: Andrew Smith

With targeted drug and gene therapies, finding the target cells is only half the battle. Once these agents reach a cell's surface, they still have to get inside and do their job.

University of Illinois researchers say they now know how to track and map drug and gene vehicles to evaluate which are most effective at infiltrating cells and getting to their targets, insight that could guide development of new pharmaceutical agents. The researchers described their tracking system and their findings on the most effective delivery vehicles in the journal Nature Communications.

Gene therapies have shown promise in cell culture and animal studies but have been less effective in clinical trials, said study leader Andrew Smith, a professor of bioengineering at the U. of I. This class of pharmaceuticals, called biologics, are different from traditional drugs in that they need to be attached to specialized delivery agents, such as nanoparticles or proteins, to reach their intended cellular targets.

Their lack of efficacy stems from their difficulty in reaching targets within cells, and the obstacles hampering them are poorly understood, Smith said.

"We have these really great models that tell us how classical drugs work, but there's no model that works for these new biologics that have to have some additional mechanism to deliver to cells. This has been a key missing part of pharmaceutical medicine," Smith said. "If we don't understand the mechanisms of the problem, we can't solve it. Now we can pinpoint why that happens and figure out how to overcome the key bottlenecks, which has never been possible."

Smith's group combined two imaging tools to track and measure how different delivery agents entered human and mouse cancer cells. The researchers used single-molecule imaging, which allows them to observe individual molecules over time, and quantum dots, which act like tiny beacons inside cells. This allowed the researchers to see, count and track all of the delivery agents that entered the cell.

They found that molecules that are very charged are adept at getting inside cells but fail to reach their intended targets once inside.

"DNA is really charged, which is unfortunate, because that's one of the major things people are trying to deliver to cells," Smith said. "We see that it sticks to everything and doesn't get to its target."

However, molecules that are completely balanced in charge – a class called zwitterions – diffuse throughout the cell and can gain access to all of its machinery.

"It gives us some design rules for better ways to deliver genes and proteins to cells. We should avoid certain features and prioritize others – especially high-stability and zwitterionic surfaces," Smith said. "Anyone working in this area now can use this tracking technology to analyze new types of delivery agents. We only looked at a handful of cell types in our study, focusing on cancer, but these tools can evaluate any new agent that's developed for any cell type. You just need a high-quality fluorescence optical microscope, and all major research institutes have them."

The study used "empty" delivery agents – those without therapeutic cargo attached – so the next step is to use the system to track the agents actually delivering drugs or genes and observe the mechanisms along each step of the drug delivery pathway, Smith said.

"We are getting closer to solving the problem of cell delivery. This has been something that's limited medicine and gene therapy for a century," said Smith, who also is a professor in the Carle Illinois College of Medicine. "I think that the ability to track and analyze delivery in will be a huge boost to the pharmaceutical industry as it develops these types of therapeutics."

Explore further: Researchers use single-cell imaging and mathematical modeling to determine effective drug properties

More information: Mohammad U. Zahid et al. Single quantum dot tracking reveals the impact of nanoparticle surface on intracellular state, Nature Communications (2018). DOI: 10.1038/s41467-018-04185-w

Related Stories

Cholesterol rafts deliver drugs inside cancer cells

April 2, 2013

DNA, siRNA and miRNA can reprogram cancer cells – that is, if these nucleic acids could cross through the cell membrane. A University of Colorado Cancer Center study published today in the journal Therapeutic Delivery shows ...

Recommended for you

Nanoscale Lamb wave-driven motors in nonliquid environments

March 19, 2019

Light driven movement is challenging in nonliquid environments as micro-sized objects can experience strong dry adhesion to contact surfaces and resist movement. In a recent study, Jinsheng Lu and co-workers at the College ...

OSIRIS-REx reveals asteroid Bennu has big surprises

March 19, 2019

A NASA spacecraft that will return a sample of a near-Earth asteroid named Bennu to Earth in 2023 made the first-ever close-up observations of particle plumes erupting from an asteroid's surface. Bennu also revealed itself ...

The powerful meteor that no one saw (except satellites)

March 19, 2019

At precisely 11:48 am on December 18, 2018, a large space rock heading straight for Earth at a speed of 19 miles per second exploded into a vast ball of fire as it entered the atmosphere, 15.9 miles above the Bering Sea.

Levitating objects with light

March 19, 2019

Researchers at Caltech have designed a way to levitate and propel objects using only light, by creating specific nanoscale patterning on the objects' surfaces.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.